NEW INHALED GLUCOCORTICOSTEROIDS FOR ASTMA
- Authors: Knyazheskaya N.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Issue: Vol 23, No 2 (2012)
- Pages: 32
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115332
- ID: 115332
Cite item
Open Access
Access granted
Abstract
Moscow Inhaled glucocorticosteroids (ICS) are the therapy basis for persistent asthma of any degree for the long-term control of inflammatory processes. Ciclesonide (Alvesco) is a new ICS for Russian practice is a pro-drug that is activated by the lung esterases and characterized by high anti-inflammatory properties and excellent safety profile because of low oral bioavailability, rapid elimination, high plasma protein binding. The drug affects the whole bronchial tree due to small inhaled particles.
Keywords
Full Text
About the authors
N. Knyazheskaya
N.I. Pirogov Russian National Research Medical University
Email: kniajeskaia@mail.ru
References
Supplementary files
